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Influence of ovarian hormones on the central oxytocin induced 
stimulation of luteinizing hormone (LH) in ovariectomized rats
Director: Craig A. Johnston, Ph.D
Central oxytocin (oxy) can stimulate LH secretion in 
cycling female proestrous rats, but not in metestrous or 
diestrous rats. Gonadal steroids play a critical role in 
regulating the influence of oxy on LH secretion. To examine 
the influence of estradiol (E2) and/or progesterone (P4) 
directly, the effects of dose and duration of E2 and P4 
exposure on the oxy stimulation of LH release was examined in 
ovariectomized (OVX) rats. For chronic exposure, subcutaneous 
time-release pellets containing vehicle, E2, P4 or both 
hormones were implanted in OVX rats. For short term exposure, 
various doses of P4 were administered, s.c. , at 900 hr in OVX, 
E2-primed or OVX animals. Central injections of oxy were given 
through stereotaxically-placed, intracerebroventricular ( icv) 
cannulae. Plasma samples were obtained via jugular cannulae 
from the unanesthetized, freely moving rats at 10 min before 
(Pre) and at 5, 15, 30 and 60 min following icv injection.
Basal LH levels were highest in OVX animals, and responded to 
icv oxy with a modest decrease at 30 and 60 min. E2 or P4 
replacement lowered basal LH levels, and the combination of E2 
and P4 lowered basal LH even more. The results of oxy 
injection in E2-treated animals were variable, but in most 
cases caused a small increase in plasma LH. In animals treated 
with P4, alone, oxy injection did not alter plasma LH. In E2- 
primed animals, the acute injection of P4 caused a bell-shaped 
dose-response curve with low doses allowing some stimulation 
of LH release in response to central oxy injection, 2.5 mg P4 
causing a dramatic synergism with E2 on the LH response, and 
higher doses causing a diminished response. The results prove 
the stimulatory effect of centrally administered oxy can be 
seen in a pharmacological model of the proestrous female rat. 
In the absence of E2 or P4, oxy exerts an inhibitory influence 
on plasma LH. The level of stimulation by oxy on plasma LH was 
critically dependent on the optimal dose and time of P4 as 
well as E2 priming.
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CHAPTER 1 
INTRODUCTION
I. Neurotransmitt«rs/Neuropeptides and Luteinizing Hormone 
Secretion
The primary neuroendocrine factor responsible for 
triggering the preovulatory surge of luteinizing hormone (LH) 
in mammals is the hypothalamic factor, luteinizing hormone 
releasing hormone (LHRH), which directly stimulates LH release 
from gonadotrophs located in the adenohypophysis (1-3). It is 
also accepted that many other factors modulate this 
regulation. The important role which LH exerts in stimulating 
ovulation is universally recognized (3).
Several neuropeptide and neurotransmitter substances 
contained within the central nervous system have been reported 
to play a significant physiological role in the regulation of 
LHRH and LH release. Norepinephrine (NE) is a monoamine 
neurotransmitter which has been shown to consistently 
stimulate LH release in a dose-related fashion in estrogen 
and progesterone treated ovariectomized rats or in intact, 
cycling female proestrous rats (4-7). Other numerous 
neuropeptides may play a role in the neuroendocrine regulation 
of LH secretion which depends upon the presence of gonadal 
steroids. neuropeptide Y (NPY) and the related human
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pancreatic polypeptide stimulate LH secretion, but the 
response depends upon the presence of gonadal steroids (8-10). 
Steele et al (11) demonstrated that angiotensin II can 
stimulate LH secretion by working at central sites, glutamate 
has also been found to stimulate LH, but not follicle 
stimulating hormone (FSH), secretion in estrogen-treated, 
ovariectomized immature rats (12). Endogenous opioid peptide 
neurons are recognized as a hypothalamic network which exerts 
a powerful inhibitory influence on gonadotropin secretion. It 
is obvious that each of the opiate receptor subtypes in the 
hypothalamus can suppress LH release when activated by an 
appropriate opiate receptor agonist (13-14). Another 
inhibitory factor on LH secretion is GABA (15). This 
inhibitory system inhibits LH secretion via GABA receptors and 
it operates without mediation by the NE system (15). 
Corticotropin-releasing factor (CRF) can also suppress LH 
secretion, and this action is through its stimulating the 
release of hypothalamic opioid peptides (16).
II. Central role of oxytocin in LH secretion
Hormonal functions for oxytocin on the female 
reproductive system are well established. During parturition, 
oxytocin regulates the contraction of the uterine wall and, 
during lactation, oxytocin triggers milk-ejection from the 
mammary gland (17). Several studies on the maternal behavior 
(17-18) and female sexual behavior (19-21) of the rat indicate
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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that oxytocin also plays a role in these behaviors in the 
central nervous system. Other studies indicate a possible role 
for oxytocin in the neuroendocrine regulation of anterior 
pituitary hormone secretion. Synthetic oxytocin stimulates 
prolactin secretion from the anterior pituitary both in vivo 
and in vitro (21-22). Oxytocin can influence the secretion of 
ACTH from the pituitary gland (23-26). Oxytocin has also been 
reported to stimulate gonadotropin-releasing activity in vivo. 
For example, oxytocin induced an increase in number and size 
of gonadotrophs in rats and dogs, increased testicular weight, 
enhanced urinary excretion of 17-keto steroids in rabbits 
(27) , and increased urinary gonadotropin excretion (28-29). 
Recent reports indicate a physiological role for oxytocin in 
the neuroendocrine regulation of LH secretion (30-35). The 
first evidence that oxytocin might stimulate gonadotropin 
secretion was proposed in 1988 (30). It was later demonstrated 
that oxytocin can stimulate gonadotropin secretion from rat 
anterior pituitary cells in static culture (3 6). These 
findings suggest that the observed accelerated follicular 
maturation and ovulation in mice given oxytocin might have 
been a result of oxytocin-induced release of pituitary 
gonadotropins, although the endocrine events were not 
elucidated (37). Oxytocin is released directly into the 
hypophyseal portal blood system and could, therefore, affect 
LH secretion directly from the anterior pituitary (35-36). 
Furthermore, oxytocin neurons send projections which terminate
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in many areas of the brain containing cell bodies or terminals 
of LHRH neurons or other LHRH secretagogues (38-42). However, 
there is a controversy concerning how oxytocin influences LH 
secretion. Some reports have indicated that the actions of 
oxytocin on LH release are primarily inhibitory in nature and 
are mediated through actions on central LHRH neurons (36) . 
other reports suggest the action of oxytocin on LH release is 
minor at best (43) . On the other hand, there is evidence 
supporting a physiologically relevant stimulatory influence 
of oxytocin on the secretion of LH from the anterior pituitary 
mediated primarily at a central site (30). These actions 
result in the preovulatory release of LH (32) . The latter 
studies utilized a physiological animal model of the female 
cycling rat on proestrus (when plasma levels of estradiol are 
physiologically high). The earlier studies showing inhibitory 
or little action of oxytocin on LH release used male or 
ovariectomized female rats (both of which have low plasma 
estradiol levels). The results indicate that in order for 
oxytocin to stimulate LH secretion, physiologically high 
levels of estradiol must be present (32).
Much evidence suggests estradiol plays a predominant 
role in the excitation of preovulatory LH release. From a 
variety of experiments, it is apparent that estradiol is 
required for the stimulation of LH release in ovariectomized 
rats (6, 8, 9, 11). Estrogens and progesterone have also been 
shown to increase the number of oxytocin receptors in some
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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areas of the brain (44-45). Additionally, gonadal steroids, in 
particular estradiol, are known to have multiple effects upon 
central oxytocin neurons. Administration of estradiol enhances 
the electrical activity of magnocellular oxytocin neurons (44- 
45), stimulates oxytocin secretion into the pituitary portal 
circulation (46) , and releases oxytocin associated neurophysin 
into the peripheral circulation (47-49). Finally, receptors 
for estradiol are found on central oxytocin neurons (3) but 
not on central LHRH neurons.
1) Distribution of oxytocinergic neurons in the central 
nervous system
Oxytocin, synthesized in the hypothalamus and released 
from the posterior pituitary, has been associated with 
immunoreactive neurons not only in the classical magnocellular 
groups (the paraventricular and supraoptic nuclei), but also 
in the anterior commissural nucleus, medial preoptic area, 
periventricular stratum, intersupraopticoparaventricular 
(internuclear) group, perifornical nucleus, nucleus 
circularis, zona incerta and the ventral nucleus of ansa 
lenticularis (50-51). Besides the well-known projections to 
the posterior pituitary, oxytocinergic neurons project to the 
external zone of the median eminence (52), to the brain stem 
and spinal cord (53), and to olfactory and limbic targets (54- 
56) .
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2) Estradiol interactions with central oxytocin neurons
Oxytocin's involvement with reproductive functions 
centering on parturition and maternal and receptive behavior 
may be, in part, influenced by estrogen. Concentrations of 
oxytocin in the pituitary have been found to fluctuate with 
the estrous cycle (57), Oxytocin levels in the portal blood 
increase on the afternoon of proestrus, correlating with the 
onset of sexual receptivity as well as the preovulatory LH 
surge (47). Estrogen treatment can increase oxytocin release 
from the pituitary (58). Correspondingly, oxytocin content of 
anterior commissural neurons decreases with estrogen 
treatment, perhaps associated with increased oxytocin release 
from these neurons (59). Some oxytocin immunoreactive neurons 
in portions of the paraventricular nucleus and a few cells in 
the anterior commissural nucleus accumulate estrogen in the 
cell nucleus (60-62). These immunocytochemical studies show 
both increased oxytocin immunoreactivity and increased 
distribution of oxytocin immunoreactive neurons following 
estrogen treatment in the anterior commissural nucleus, 
anterior hypothalamic area, septohypothalaroic nucleus, medial 
preoptic area, perifornical nucleus, and zona incerta (50-51, 
61) .
Recent experiments have utilized in situ hybridization 
to study possible estrogen influences on oxytocin messenger 
RNA levels. These studies concentrated on preoptic and 
anterior hypothalamic levels because of the possible
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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involvement of oxytocin in LHRH function influencing LH 
release (30) and because of demonstrated preoptic sites of 
action of oxytocin in female sexual behaviors (63). Analysis 
of oxytocin-expressing neurons included the numbers of cells 
labeled with in situ hybridization procedures as well as the 
numbers of grains per labeled cell because these two 
parameters can change independently.
The possibility of direct involvement of estradiol with 
oxytocin or vasopressin-producing neurons was suggested by 
observations of tritiated estradiol binding in the cell nuclei 
of neurophysin-immunoreactive neurons (61-62). Using northern 
blot and dot blot analysis» Van Toi et al (64) demonstrated a 
significant increase in oxytocin mRNA levels during the 
estrous phase of the female rat's cycle to almost twice the 
levels seen on diestrus. Oxytocin mRNA in the brain of the 
female rat is increased concomitant with puberty, and 
ovariectomy of adult females decreased oxytocin mRNA values 
(65); both observations consistent with estrogen stimulation 
of oxytocin. Significant elevations of oxytocin mRNA during 
the late stages of pregnancy also suggest increased gene 
transcription under the influence of ovarian hormones (66). 
Radioimmunoassay of oxytocin in micropunches from the medial 
preoptic area revealed significantly increased levels in 
estrogen-progesterone-treated animals which were behaviorally 
receptive (59), while the number of immunocytochemically 
detectable oxytocin cell bodies actually decreased. This
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configuration of results suggested a greater amount of 
expression per oxytocin-producing neuron. Jirikowski et al 
(51) reported a stimulatory effect of short-term estradiol 
treatment on the distribution of immunoreactive cell bodies. 
Greater numbers of oxytocin immunoreactive neurons were seen 
in the septohypothalamic nucleus, the lateral subcommissural 
area, the medial preoptic area, the perifornical region, the 
zona incerta, and the ansa lenticularis. Finally, a number of 
experimental approaches in different species have suggested 
strongly that estrogen treatment facilitates oxytocin release 
(48, 58). Under these circumstances, where release is
increased by estrogen and immunoreactive content is either not 
changed or is increased, elevated transcription and/or mRNA 
stability is to be expected.
The mechanisms of estrogen effects on oxytocin mRNA 
levels are unclear. The possibility of a direct effect of the 
estrogen receptor on transcription is indicated by the 
presence of these partial estrogen-response-elements upstream 
to the oxytocin transcription start site (67-69) . On the other 
hand, significant numbers of supraoptic neurons with nuclear 
estrogen receptors have not been identified (70). There may be 
an analogy to control of the LHRH gene, where a long estrogen 
treatment can lead to increased mRNA levels (71-72) and where 
the stimulatory effects of estrogen can be interpreted as 
consequent to the release of the neuroendocrine peptide (73). 
Co-existence of oxytocin and of estrogen receptor in the same
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neurons raises questions regarding their possible functional 
significance. Changes in the oxytocin levels in circulation 
after estrogen treatment (58) and during the estrous cycle in 
the PVN (74) and in the pituitary (57) have been reported. 
Results of these studies suggest that physiological 
fluctuation in ovarian steroid levels affect the release of 
neurohypophyseal hormones. Although the intensity of oxytocin 
immunostaining of perikarya and processes in several brain 
sites vary after estrogen treatment, it is impossible to 
explain whether the increased immunostaining after estradiol 
treatment is due to an increased synthesis of peptide or to an 
inhibition of its secretion. Existence of estrogen receptor 
protein in an identical population of neurons does not 
represent complete proof that estrogen regulates the synthesis 
of that peptide. However, recent studies using a hybridization 
assay on the levels of rat hypothalamic oxytocin mRNA during 
gestation, lactation and the estrous cycle (64,75-76) have 
shown that the expression of oxytocin gene was stimulated 
concomitantly with an increase in serum estrogen levels during 
the estrous cycle and pregnancy (77). These observations 
suggest that estrogens may be involved in regulating oxytocin 
gene expression. Recent studies by Richard and Zingg (78) , 
demonstrate that beta-estradiol administration stimulates the 
transcriptional activity of the human oxytocin gene promoter 
by a direct estrogen receptor dependent mechanism. Anatomical 
evidence that an estrogen-stimu1ated release of oxytocin from
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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the posterior pituitary is mediated by a direct effect of 
estrogen on magnocellular hypothalamic neurons has also 
recently been published (79),
3) Gonadal hormones and LH secretion
Although a lot of evidence gathered over the years has 
documented the feedback action of gonadal steroids in the 
hypothalamus and pituitary in the neuroendocrine regulation of 
LHRH and LH secretion, the mechanisms involved in these 
actions have not yet been precisely delineated.
Several lines of evidence indicate that estradiol is the 
critical stimulus for the preovulatory surge of gonadotropins. 
In intact cycling female rats, the serum levels of LH are low 
from early on the morning of estrus, shortly after ovulation, 
through metestrus, diestrus, and midday on proestrus (80) . 
Though most studies have reported basal unchanging levels of 
LH over this time (80-84), one study reported a significant 
diurnal variation throughout the cycle (85). This circadian 
pattern from estrus through diestrus consisted of a small 
elevation of LH each day at the midpoint of the light period, 
and the lowest levels by midnight of each day. On the late 
afternoon of proestrus (actual time of initiation depending on 
the light cycle) the circulating levels of LH begin to 
increase rapidly and ultimately reach peak levels by 1700-1900 
hr on that same evening. This rapid surge of LH induces 
follicular rupture and ovulation. Thereafter, the blood levels
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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of LH begin to decline and reach basal levels by early on the 
morning of estrus.
There is a voluminous literature indicating that ovarian 
estradiol, secreted on diestrus, is a critical positive- 
feedback stimulus for the ovulation-inducing surge Of LH. 
Several experimental approaches have attested to this fact. 
Specifically, under either a 14:10 or 12:12 light-dark cycle, 
with noon as the midpoint of the light interval (86) , 
ovariectomized rats will respond to a dose of exogenous 
estradiol by presenting a proestrous-like LH surge the 
following day with the same timing and duration as the intact 
female rat on proestrus (86-88), However, the magnitude of 
this induced surge differs from that of the spontaneous surge 
on proestrus. That is, base-line values are not as low and 
peak values are not as high as those obtained during the 
endogenous surge on proestrus. In addition, rather than 
stimulating a surge of LH on a single day, estradiol 
administration to ovariectomized animals results in an LH 
surge of equivalent timing on each of at least the following 
3 days. Thus, a daily neural event must be coupled with the 
presence of estrogen to eventuate in a daily LH surge in the 
ovariectomized rat. This confirms Everett and Sawyer's 
original proposal (89) of a 24 hr. periodicity in the LH 
release apparatus. Other approaches have demonstrated that 
ovarian estradiol secreted on diestrus is required to activate 
the LH surge response on proestrus. Specifically,
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administration of estrogen inhibitors (90) or estradiol 
antiserum (90-92) or ovariectomy (93) on diestrus bloc)cs the 
proestrous surge of LH. On the other hand, administration of 
these agents or removal of the ovaries early on proestrus is 
ineffective in preventing this response later that same day. 
These data, taken together, suggest that the rising titer of 
estradiol secreted on diestrus represents a major stimulus for 
the increased secretion of LH on proestrus. The tonic levels 
of LH secreted on diestrus contribute to the stimulation of 
estradiol secretion by the ovarian follicle which, in turn, 
stimulates LH secretion (94).
The long-term ovariectomized rat responds to a brief 
exposure (only 4 to 5 days) to estradiol with daily LH surges, 
whereas the acutely ovariectomized rat requires chronic 
exposure to estradiol to secrete daily LH surges (88). Also, 
it has been shown that expression of the daily LH surge 
mechanism is limited to proestrus by the heightened secretion 
of progesterone on proestrus (87). Thus, there is every 
indication from the present data as well as previous reports 
that progesterone contributes in a positive way to the 
secretion of the surge of LH on proestrus. In fact, 
progesterone administered early on the morning of proestrus 
will advance LH release by several hours (95). Similarly, 
progesterone administrated to ovariectomized, estradiol- 
benzoate-pretreated rats will induce an LH surge during the 
afternoon of that same day (106) . In addition, progesterone
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will enhance the magnitude of the estrogen-induced LH surge 
(96). The effect of estrogen to increase LHRH release may not 
be exerted directly on LHRH-containing neurons since only 1 in 
435 LHRH neurons reportedly have estrogen receptors (97) . The 
effect of progesterone appears not to be mediated through the 
ovary since studies in the rat have shown progesterone 
stimulates gonadotropin secretion in bilaterally 
ovariectomized rats primed with estradiol (98-100). The 
stimulatory effect of progesterone does, however, require the 
presence of estradiol, as evidenced by the lack of effect of 
progesterone on gonadotropin secretion in ovariectomized rats 
not given estrogen replacement (101-102). The critical 
dependence of progesterone on estradiol for the induction of 
progesterone receptors is important (103-104); however, 
estradiol may also exert other important priming effects, such 
as setting the neural trigger for progesterone activation. On 
the other hand, the data also suggest that the proestrous 
surge of LH may be terminated, in part, by the secretion of 
progesterone.
Progesterone's effect upon gonadotropin secretion is 
dependent not only upon time of administration but also upon 
the dose of administration. Freeman et al (105) found that the 
injection of progesterone to estradiol benzoate-treated, long­
term ovariectomized rats resulted in an enhancement of the LH 
surge on the first day, and elimination of the surge on 
following days (105). The role of endogenous progesterone to
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limit the expression of the gonadotropin surge to a single day 
was further confirmed by the study of Smith et al (106), who 
demonstrated that blockade of progesterone's effects on the 
afternoon of proestrus with either progesterone antibody 
administration or the antiprogestin, RU486, caused a return of 
pulsatile LH secretion on estrus.
In addition to direct effects at the anterior pituitary, 
progesterone may regulate hypothalamic release and degradation 
of LHRH as a mechanism in its positive feedback effect on 
gonadotropin secretion; however, it appears unlikely that this 
action of progesterone is exerted directly on LHRH-containing 
neurons since progesterone receptors are not reported to be 
present on hypothalamic LHRH neurons (107), It appears more 
likely that progesterone's effect on LHRH is exerted through 
neurotransmitter/neuropeptide-containing neurons in the 
hypothalamus which interact with LHRH neurons.
Numerous studies have demonstrated that progesterone 
enhances the pituitary response to LHRH (108-113). Acute 
progesterone treatment enhances, while chronic treatment 
suppresses, the pituitary response to LHRH. The cellular 
mechanism involved in the acute progesterone enhancement of 
LHRH response is unclear. One possible mechanism could be the 
modulation of LHRH receptors. However, a recent study by 
Attardi and Happe (110) failed to show any effect of 
progesterone on LHRH receptor number in the pituitary, 
suggesting the site of progesterone action could be
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independent of effects on the LHRH receptor. Krey and Kamel 
(111) recently reported that progesterone enhances the 
pituitary LH response to secretagogues which act separate from 
the LHRH receptor.
Progesterone can modify the action of estradiol by 
decreasing nuclear estradiol receptor retention (114-115) . The 
reduction of occupied nuclear estradiol receptors is 
equivalent to causing a fall in serum estradiol levels, 
because estradiol * s action is exerted through its occupied 
nuclear receptors.
These reports demonstrate the crucial role played by 
progesterone in the regulation of gonadotropin secretion. The 
regulatory role of progesterone on gonadotropin secretion 
depends on the time and dose of its administration in 
relationship to the adequacy of estrogen priming.
All this information suggests to us that the effects of 
estradiol and progesterone are partly exerted through other 
neurotransmitter(s)/neuropeptide(s), and the central role of 
those factors. Verification of this hypothesis requires more 
research. The review summarized here suggests that oxytocin 
neurosecretion, itself, as well as its central influence on LH 
secretion, is subject to modulation by gonadal steroids and 
may represent a significant portion of this neuroendocrine 
control.
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CHAPTER II 
OBJECTIVES:
The major objectives of this research are to 1) 
demonstrate the important role of central oxytocin in the 
regulation of LH secretion in the pharmacological model of the 
proestrous LH surge, 2) to determine and characterize if that 
stimulatory role is influenced by gonadal hormone levels in 
vivo and 3) to study the interaction of different gonadal 
hormones on the oxytoe in-induced stimulation of LH secretion.
Previous experiments in our laboratory suggest that 
central oxytocin neurons may exert a physiologically important 
stimulatory influence on the release of LHRH and LH occurring 
just prior to ovulation on the afternoon of proestrus in the 
cycling female rat (when estradiol levels are physiologically 
high)(32). Another recent report showed that the in vitro LH 
response to oxytocin at the anterior pituitary level is 
steroid-dependent(106). This research tested the hypothesis 
that the central stimulatory role of oxytocin on LH secretion 
is subject to modulation by the levels, concentration ratios 
and time of exposure of gonadal hormones.
To investigate these possibilities, we utilized 
ovariectomized, estrogen, or both estrogen and progesterone- 
primed female rats as an in vivo pharmacological model for the 
proestrous female rat. The results were planned to further
16
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confirm the central effect of oxytocin on LH release and the 
dependence of its action on plasma estradiol and progesterone 
levels in a pharmacological model for the preovulatory surge.
The knowledge gained from this research might advance our 
basic understanding of the nature, site, mechanism and 
physiological significance of oxytocin in regulating the 
preovulatory surge of LH and the influence of gonadal hormones 
on that neuroendocrine regulation. It might also offer an 
ideal experimental model for the study of the interaction 
between oxytocin and other physiologically relevant LHRH 
secretagogues.
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CHAPTER III 
MATERIALS AMD METHODS
1) Animals:
Young adult female, ovariectomized, Sprague Dawley rats 
(200-300 g, BW) were housed in a temperature (22±l*C) and 
light ( light on 700-1900 h) controlled room. Ovariectomies 
were done at least 4 weeks prior to further experiments. The 
rats were supplied food and water ad libitum.
2)Surgery:
a. Third ventricular cannulae placement (icv):
Stainless-steel 23 gauge cannulae were stereotaxically 
placed into the third cerebral ventricle of the ovariectomized 
rats using the atlas of Kdnig and Klippel (107) as a guide 
under tribromoethanol (1 ml/100 g B.W. of a 2.5% solution in 
saline) anesthesia. Coordinates utilized for placement of the 
icv cannulae were lateral 0.0 mm from midline, 2.5 mm 
posterior to bregma, and approximately -8.5 mm ventral to the 
surface of the brain. Each cannula was secured with dental 
cement and fine microscrews, and was provided with a screw-in 
mandril to prevent its obstruction. Location of the cannulae 
were confirmed by the flow of cerebrospinal fluid through the 
cannulae after removal of the mandril and by a positive
18
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drinking response to the icv injection of 10 ng angiotensin II 
(a positive drinking response started not more than one minute 
after icv injection of angiotensin II with a total consumption 
of water of greater than 3 ml within 3 0 minutes).
At the time of the experiment, the mandril of the 
cannulae were removed and injections were made using a 10 
microliter Hamilton (Hamilton Industries, Two Rivers, WI) 
microsyringe connected by polyethylene tubing (PE 10) to a 3 0 
gauge stainless steel infusion needle which fits within and 
extends to the lower lip of the chronic third ventricular 
cannula. The tubing and needle were filled with freshly made 
solution to be injected just prior to the injection.
b. Jugular cannulae:
Silastic cannulae were placed in the right atrium via the 
external jugular vein under tribromoethanol (TBE) anesthesia 
(1 ml of 2.5% solution/100 gm BW), secured to the pectoral 
muscle, threaded subcutaneously and externalized at the base 
of the neck on the rat’s back (108) . The cannulae were 
connected to extensions running outside the cages 2-3 h before 
further experimentation.
3) Estradiol, progesterone and LH radioimmunoassays:
Plasma samples were assayed for estradiol and 
progesterone levels using a double antibody radioimmunoassay 
(RIA, Diagnostic Assay Services, Gaithersburg, ML). The
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sensitivities of the RlAs for estradiol and progesterone were 
1.0 ng/liter and 1.0 ng/ml, respectively, with intraassay 
coefficient of variation of 8 and 11%, respectively.
Serum LH levels were measured by double antibody 
radioimmunoassay. The sensitivity of this assay was 0.5 
ng/tube, with an intraassay coefficient of variation of 7-8%.
All samples from the same experiment were assayed in the 
same RIA.
4) Statistical analysis:
Data were analyzed by one-way analysis of variance with 
the student-Newman Keuls post-hoc test or the Student's t- 
test. The 0.05 level of probability was used as the minimum 
level of significance for differences between the means for 
all experiments.
5) Drugs and chemicals:
All the drugs to be employed in the proposed experiments 
were available from commercial sources. Purified preparations 
of angiotensin II and oxytocin were available from Peninsula 
Laboratories (San Carlos, CA). HPLC-purified 125-1 rat LH was 
obtained from Hazleton Laboratories (Vienna, Virginia). Other 
chemicals and reagents including progesterone were purchased 
from Sigma Chemical Company (ST. Louis, MO). The pellets for 
17-beta estradiol, progesterone and their placebo carrier- 
binder were purchased from Innovative Research of America 
(Toledo, OH) . Chemicals for intravenous injections were
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diluted in saline.
6) Experimental procedure
Effect of gonadal hormones on the stimulatory effect of 
oxytocin on LH secretion.
1)Long term exposure to high doses of estradiol and/or 
progesterone:
Ovariectomized female rats were separated into 4 groups 
(7-8 rats/group). Pellets containing placebo carrier-hinder 
(control group), 17-beta estradiol (1 mg, E2 group), 
progesterone (35 mg, P4 group) or both estradiol and 
progesterone (1 mg 17-beta estradiol and 3 5 mg progesterone, 
E2/P4 group) were placed subcutaneously 4 days prior to 
further experimentation.
2) Short term exposure of varying progesterone doses in 
ovariectomized rats with or without estradiol-priming:
Ovariectomized female rats were separated into 6 groups 
(7-8 rats/group) . Rats received subcutaneous 17-beta estradiol 
pellets (1 mg) 2 days prior to further experimentation. On the 
day of the experiment, various doses of progesterone (15 mg, 
5 mg, 2.5 mg, 1.5 mg, 0.5 mg or 0.0 mg/rat in vegetable oil 
vehicle) were administered, subcutaneously [P4(2.5), P4(1.5), 
P4(0.5), control, E-P4(15), E-P4(5) groups] in the
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ovariectomized rats primed with estradiol. Four other groups 
of ovariectomized rats (7-8 rats/group) received various doses 
of progesterone [25 mg, 15 mg, 5 mg/rat or 0 mg/rat in 
vegetable oil vehicle; P4(25), P4(15), P4(5) and control
groups, respectively].
Rats were housed and maintained according to guidelines 
published in "NIH Principles for Use of Animals, Guide for 
Care and Use of Laboratory Animals". All surgical procedures 
were classified as USDA type D procedures. The surgery for 
jugular cannulae placement takes approximately 5-10 min and 
the stereotaxic ICV cannulae placement surgery takes 20-30 
min. Sterilized materials and prophylactic antibiotics 
(intramuscular injection and local ointment) were administered 
to prevent infections for all recoverable surgeries. Any rats 
displaying signs of illness were euthanized so they did not 
suffer, consistent with the recommendations of the panel on 
Euthanasia of the American Veterinary Medical Association.
Approximately 145 female rats were used for these 
experiments. All precautions were taken to avoid any stress in 
handling the rats, which could affect the release of LH.
Plasma samples were obtained via jugular cannulae (placed 
2 days earlier) from the unanesthetized, freely moving rats at 
10 min before (PRE) and at 5, 15, 30, and 60 min following 
oxytocin (10 ng) icv injection. Blood obtained from samples 
were transferred to heparinized tubes and separated 
immediately at 4*C. Plasma samples were stored at -80®C until
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analyzed by RIA. lev experiments started at 1300 hr (4 hours 
after progesterone injection).
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CHAPTER IV 
RESULTS :
1. Long term exposure of high doses of estradiol and/or 
progesterone on oxytocin induced LH release
The results indicate that basal LH was higher in control, 
ovariectomized rats treated with subcutaneous pellets 
containing placebo carrier-binder than in groups treated with 
subcutaneous pellets containing estradiol, progesterone or 
both hormones (Fig 1) . Furthermore, ovariectomized animals 
(control group) responded to icv oxytocin with a modest 
decrease in plasma LH at 30 and 60 min after icv injection 
(Fig 2). Estradiol or progesterone treatments, alone, 
decreased basal LH levels compared to control ovariectomized 
animals (Fig 2; Pre time point). ICV oxytocin caused a modest 
increase in plasma LH at 5, 15, and 30 min in estradiol-
treated animals compared with the proestrous LH surge in the 
intact, cycling female rats (Fig 2) . ICV oxytocin 
administration to progesterone-treated animals caused little 
change in plasma LH. In animals treated with both estradiol 
and progesterone, basal LH levels were significantly lower 
than in any other treatment groups (Fig 1 and Fig 2; Pre time 
point). The icv injection of oxytocin to chronic estradiol and 
progesterone treated animals resulted in no change in plasma 
LH (Fig 2; E2/P4 group).
24
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
25
Figure l. Effect of chronic replacement therapy with 
subcutaneous pellets containing placebo carrier-binder (CNTRL 
group)t 17 8-Estradiol (1 mg, E2 group) , progesterone (35 mg, 
P4 group), or both E2 and P4 (E2/P4 group) 2-4 days prior to 
further experimentation on basal plasma concentrations of 
luteinizing hormone. Column height represents mean and 
vertical bars represent SEM as determined from N = 7-8 rats. 
A, significantly different from all other mean values 
(P<0.01). *, significantly different from CNTRL mean value
(P<O.OX) .
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Figure 2. Effect of a central injection of oxytocin (10 ug/ 
5ul) on plasma LH concentrations in ovariectomized rats which 
have received subcutaneous pellets containing placebo carrier- 
binder ( CNTRL group), 17 6-Estradiol (1 mg, E2 group), 
progesterone (35 mg, P4 group) , or both E2 and P4 (E2/P4 
group) 2-4 days prior to further experimentation. At 13 00 hr 
of the experimental day animals received an icv injection of 
oxytocin and plasma samples were collected 10 min prior to icv 
injection (Pre) , or 5, 15, 30 or 60 min after the icv
injection for plasma LH determination. Values represent mean 
plasma LH concentration as determined from N = 7-8 rats.
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2. Short term exposure to various progesterone doses in 
ovariectomized rats with or without estradiol priming on 
oxytocin-induced LH release
The effect of short term exposure to various progesterone 
doses in estradiol-primed, ovariectomized rats on the 
oxytocin-induced stimulation of LH release were investigated. 
Once again, the results indicate that basal LH is highest in 
ovariectomized rats, next highest in animals treated with 
estradiol alone (Fig 3; Pre time values), and lowest (in a 
dose-related manner) in those treated with high doses of 
progesterone, alone [25 mg, P4(25) group; 15 mg, P4(15) group 
or 5 mg, P4(5) group; Pre time values in Fig 4]. Oxytocin 
injection did not alter plasma LH in animals treated with any 
of the progesterone doses, alone (Fig 4) . Following estradiol 
treatment, alone, a very small decrease was seen at 5 min and 
a small increase in plasma LH was seen at 15 and 30 min after 
oxytocin injection (Fig 4, E group). In estradiol-primed, 
ovariectomized rats treated acutely with 15 mg [E-P4(15) 
group] or 5 mg [E-P4 (5) group] progesterone at 900 hr, icv 
administration of oxytocin 4 hr later caused an increase in 
plasma LH (Fig 5) . This increase was significantly higher than 
that seen in animals treated with estradiol, alone (E group. 
Fig 5) , in animals receiving the lower dose of progesterone 
[E-P4(5) group. Fig 5] at 5 min-30 min. In animals receiving
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Figure 3. Effect of a central injection of oxytocin (10 ug/5 
ul) on plasma LH concentrations in ovariectomized rats which 
have received subcutaneous pellets containing placebo carrier- 
binder (CNTL group) or 17 6-Estradiol (1 mg, E group) 2 days 
prior to further experimentation. At 13 00 hr of the 
experimental day, animals received an icv injection of 
oxytocin and plasma samples were collected 10 min prior to icv 
injection (Pre), or 5, 15, 30 or 60 min after the icv
injection for plasma LH determination. Values represent mean 
plasma LH concentration as determined from N = 7-8 rats.
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Figure 4 . Effect of a central injection of oxytocin (10 ug/5 
ul) on plasma LH concentrations in ovariectomized rats which 
have received subcutaneous pellets containing 17 6-Estradiol 
(1 mg, E group) 2 days prior to further experimentation, or an 
acute subcutaneous injection of progesterone at 25 mg/0.6 ml 
oil [P4(25) group], 15 mg/0.3 ml oil [P4(15) group], or 5 
mg/0.3 ml oil [P4 (5) group ] at 900 hr of the experimental day. 
At 13 00 hr an icv injection of oxytocin was administered and 
plasma samples were collected 10 min prior to icv injection 
(Pre) , or 5, 15, 30 or 60 min after the icv injection for
plasma LH determination. Values represent mean plasma LH 
concentration as determined from N = 7-8 rats.
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Figure 5. Comparison of the effect of a central injection of 
oxytocin (10 ug/5ul) on plasma LH concentrations in 
ovariectomized rats which have received subcutaneous pellets 
containing 17 6-Estradiol (1 mg) 2 days prior to further 
experimentation either without (E group) or with an acute 
subcutaneous injection of progesterone at 15 mg/0.3 ml oil [E- 
P4(15) group) or 5 mg/0.3 ml oil [E-P4(5) group] at 900 hr of 
the experimental day. At 1300 hr an icv injection of oxytocin 
was administered and plasma samples were collected 10 min 
prior to icv injection (Pre), or 5, 15, 30 or 60 min after the 
icv injection for plasma LH determination. Values represent 
mean plasma LH concentration as determined from N = 7-8 rats.
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the higher dose of progesterone [E-P4 (15) group. Fig 5] the LH 
stimulation resulting from icv oxytocin administration was 
smaller and of shorter duration than even in the estradiol, 
alone, treatment group; suggesting that higher doses of 
progesterone may inhibit the oxytocin-induced release of LH. 
To test this directly, ovariectomized, estradiol primed rats 
were give acute injections of 2.5 mg [P4(2.5) group], 1.5 mg 
[P4(1.5) group] or 0.5 mg [P4(0.5) group] progesterone or 0.3 
ml oil vehicle at 9:00 hr and then given an icv injection of 
oxytocin at 1300 hr in order to evaluate the effect of the 
dose of progesterone on the oxytocin-induced increase in 
plasma LH in estradiol-primed rats. Oxytocin elicited a 
maximum response in plasma LH in animals given an acute 
injection of 2.5 mg progesterone, with a surge which increased 
5 min after icv injection, peaked at greater than 60 ng/ml at 
3 0 min and was still significantly elevated over control 
animals at 60 min [P4(2.5) group. Fig 6]. Oxytocin induced a 
much smaller, but significant, increase in plasma LH in 
ovariectomized, estradiol-primed animals treated acutely with 
1.5 mg progesterone [P4(1.5) group. Fig 6] with increased 
plasma LH levels at 5-30 min after icv injection, peaking with 
a value of about 25 ng/ml at 5 min after icv injection. The 
effect of icv oxytocin in animals receiving the lowest dose of 
progesterone [0.5 mg, P4 (0.5) group. Fig 6] showed a much 
smaller stimulation with small increases in plasma LH being 
observed at 5 min and at 60 min after icv injection of
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oxytocin. Interestingly, in the animals receiving estradiol 
priming, alone, no significant effect of icv oxytocin on 
plasma LH was observed.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
38
Figure 6; Comparison of the effect of a central injection of 
oxytocin (10 ug/5 ul) on plasma concentrations in
ovariectomized rats which have received subcutaneous pellets 
containing 17 6-estradiol (1 mg) 2 days prior to further 
experimentation and an acute subcutaneous injection of
progesterone at 2.5 mg/0.3 ml oil [P4(2.5) group]; 1.5 mg/0.3
ml oil [P4(1.5) group] or 0.5 mg/0.3 ml oil [P4(0.5) group]; 
or received 0.3 ml oil vehicle (CNTRL group) at 900 hr of the 
experimental day. At 1300 hr an icv injection of oxytocin was 
administered and plasma samples were collected 10 min prior to 
icv injection (Pre), or 5, 15, 30 or 60 min after the icv
injection for plasma LH determination. Values represent mean 
plasma LH concentration ±sem as determined from N=7-8 rats.
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CHAPTER V
DISCUSSION:
The data demonstrate that for the expression of the 
stimulatory role of oxytocin on plasma LH to be seen, serum 
levels, concentration ratios and exposure time of gonadal 
hormones are critical. This stimulatory action of oxytocin 
disappears when estradiol is removed. Furthermore, although a 
small dose of progesterone synergizes with estradiol to cause 
a greater release of LH by oxytocin, the action is reduced as 
the dose of acutely administered progesterone increases in the 
ovariectomized, estrogen-primed rats (Fig 6).
The data from the present study agree with previous 
reports (30, 32) that oxytocin exerts a physiologically
relevant, stimulatory influence on the preovulatory release of 
LH on the afternoon of proestrus in cycling female rats (when 
the concentration of plasma estradiol level is high and 
progesterone is low, but increasing). Pharmacological 
manipulation of endogenous oxytocin with selective oxytocin 
antagonists and passive immunoneutralization with specific 
oxytocin antisera result in significant deficiencies in 
stimulated LH release in animal models with similar estradiol 
and progesterone concentrations (30, 32) . Recently, Samson et
40
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al (119) developed a novel method to selectively lesion 
central oxytocin neurons with a ricin-cytotoxin conjugate to 
reveal a physiologically relevant role for oxytocin within the 
hypothalamus to control LHRH release on the afternoon of 
proestrus in the steroid-primed LH surge model (119). Our 
results provide a possible explanation for data from several 
laboratories describing both inhibitory and stimulatory 
effects of oxytocin on LH. Changes in the concentration of 
plasma gonadal hormones are critical to the action and effect 
of central oxytocin on LH secretion. Two studies demonstrating 
inhibitory effects of oxytocin on LH release were carried out 
in animal models associated with low levels of ovarian 
hormones (34, 43) . On the other hand, another group has
provided evidence for a direct, stimulatory action of oxytocin 
on LH release from rat anterior pituitary cells in static 
culture (31, 35), which is steroid-dependent (106). We have 
shown pretreatment with either an oxytocin antagonist or an 
LHRH antagonist blocked the increase in plasma LH resulting 
from a central injection of oxytocin on proestrus (when plasma 
concentrations of gonadal steroids are high) (12 0). These 
results demonstrate that the oxytocin-induced increase in 
plasma LH is an oxytocin receptor-mediated event and is 
apparently mediated by influencing the release of LHRH. 
Additionally, using oxytocin-ricin A chain conjugates to 
selectively target and destroy cells in vivo and in vitro that 
possess oxytocin receptors, Samson and co-workers failed to
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demonstrate that oxytocin acts directly on the anterior 
pituitary, and provided evidence that oxytocin acts through 
LHRH neurons centrally to affect LH release.
Evidence supporting the influence of plasma estradiol and 
progesterone on distribution, content, synthesis, and release 
of oxytocin in the CNS has been provided. Treatment with 
estradiol has been shown not only to enhance the oxytocin-like 
immunoreactivity contained in discrete regions of the rat 
brain (20), but also allows additional immunoreactive oxytocin 
perikarya and processes to be observed in areas which 
demonstrate no oxytocin-like immunoreactivity prior to 
estradiol treatment (50, 51, 58) . The concentrations of
oxytocin found in CNS nuclei fluctuate within the estrous 
cycle (57). Oxytocin levels in the portal blood increase on 
the afternoon of proestrus, correlating with the onset of the 
preovulatory LH surge (47). Studies examining the possible 
influence of estrogen on oxytocin messenger RNA levels using 
Northern blot and dot blot analysis provide evidence for a 
role at the molecular level (64-66). The possibility of a 
direct effect of estrogen on transcription is indicated by the 
presence of partial estrogen-responsive-elements located 
upstream to the oxytocin transcription start site (67-69), 
However, autoradiographic studies of estrogen binding have not 
revealed significant numbers of supraoptic neurons with 
nuclear estrogen receptors (70) . This is unlikely to represent 
the only route of gonadal hormone action on the oxytocin
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system. Other possibilities include the modification of 
hormone responsiveness by increasing the sensitivity of 
putative second messenger systems or membrane potential to 
oxytocin. For LHRH gene expression, a long estrogen treatment 
can induce increased roRNA levels and the stimulatory effects 
of estrogen can be consequent to the release of the 
neuroendocrine peptide (71-73) . All these results suggest that 
the increasing activity of oxytocin neurons during proestrus 
(when plasma estradiol levels are high) is probably 
physiologically responsible for inducing the LH surge. The 
results from the present study support the fact that the 
stimulatory effect of centrally administered oxytocin can be 
seen in a pharmacological model of the proestrous female rat, 
and that the presence of physiologically high levels of 
estradiol are critical for the stimulatory effect of oxytocin 
to be seen.
Our results demonstrate that progesterone also plays an 
important role in this mechanism. In our study, both estradiol 
and progesterone chronically exerted additive negative 
feedback effects on basal LH levels. ICV oxytocin inhibited LH 
levels in ovariectomized rats, and modestly stimulate LH 
levels (in most cases) in estradiol treated rats compared with 
the proestrous LH surge in cycling female rats, but not in 
rats treated with the highest dose of progesterone. This 
suppressive action of progesterone is reduced and even begins 
to synergize with estradiol when the acute dose of
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administered progesterone is reduced to 0.5-5 mg/rat (Fig 5, 
Fig 6) . This result is consistent with the fact that 
progesterone administered early on the morning of proestrus 
advanced LH release by several hours and enhanced the 
magnitude of the estrogen-induced LH surge (96). The effect of 
progesterone appears not to be mediated through the ovary 
since studies in the rat have shown progesterone to stimulate 
LH release in ovariectomized rats primed with estradiol (98- 
100) . However, our studies show that the stimulatory effect of 
progesterone required the presence of estradiol. These facts 
are consistent with the negative feedback of the gonadal 
hormones on the basal release of LH. The results also relate 
to the general mechanisms by which gonadal hormones exert 
their effects on different locations in the CNS to control LH 
secretion; including effects on neurotransmitter synthesis and 
release dynamics, to receptor number and affinity. The 
requirement of estradiol priming for progesterone * s 
stimulatory effect to be exhibited is obvious and may be due 
to a critical dependence of progesterone on estradiol for the 
induction of its receptors (103-104). on the other hand, 
progesterone's action might be due to neurotransmitter release 
mechanisms while that of estradiol might be on synthesis of 
neurotransmitters. This possibility is supported by the fact 
that progesterone receptors are not found directly on 
hypothalamic LHRH neurons (107). Therefore, central oxytocin 
may represent one of the mediating factors in the action of
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gonadal steroids on LHRH neurons. The effects of estrogen on 
hypothalamic LHRH release might be mediated, in part, through 
effects on oxytocin neurons surrounding LHRH neurons in the 
hypothalamus and median eminence. Indeed, estradiol and 
progesterone receptors have been identified on central 
oxytocin neurons (121). Estrogen also exerts important effects 
which sensitize the anterior pituitary to LHRH stimulation. 
Drouva et al (122) provided evidence that estradiol increases 
anterior pituitary protein kinase C activity both in vivo as 
well as in vitro. Direct effects of estradiol on the pituitary 
have been demonstrated in ovariectomized female rats in which 
the vascular connections between the hypothalamus and the 
pituitary were interrupted surgically, and regrowth was 
prevented by insertion of a piece of aluminum foil; as well as 
in experiments using dispersed pituitary cells in culture 
(123-124). On the other hand, at the very least, gonadal 
hormones modulate the oxytocin receptors and interactions 
involved in the stimulation of LH release in terms of its 
qualitative nature, quantity, affinity and distribution. The 
central influence of gonadal steroids was also proven in 
experiments showing pretreatment with an oxytocin antagonist, 
central administration of an oxytocin antisera or an LHRH 
antagonist blocked the increase in plasma LH resulting from a 
central injection of oxytocin. Several other neuropeptides and 
monoaminergic neurotransmitters have been implicated in the 
neuroendocrine regulation of LH secretion. They primarily
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appear to work by altering the net release of LHRH from the 
median eminence into the hypophyseal portal blood. 
Surprisingly, most of the LHRH secretagogues or inhibitors 
more or less appear to be dependent on the levels of plasma 
gonadal hormones, especially physiologically high levels of 
plasma estradiol. These include NE, epinephrine, angiotensin 
II, glutamate, GAB A, CRF, NPY, and the opiates (5-16). 
However, direct evidence for these interactions and their 
significance in the neuroendocrine regulation of LHRH and LH 
secretion, as well as the modulatory influence of plasma 
estradiol/progesterone levels on those possible interactions 
is controversial and largely unknown. Further work is needed 
to clarify these issues.
Besides the modulation by estradiol of the oxytocin 
stimulation of LH release, the acute administration of 
progesterone also acted synergistically to enhance LH release 
in estradiol-primed, ovariectomized rats in dose-related 
manner (Fig 5; Fig 6). How progesterone acts centrally to 
exert this action on LH release remains unresolved. The 
regulatory role of progesterone on the neuroendocrine 
regulation of LH secretion depends on the time and dose of its 
administration in relationship to the plasma level of 
estradiol. Long term administration of high doses of 
progesterone failed to show the synergistic effect when serum 
estradiol levels were similar to those attained in the most 
recent experiments demonstrating synergism (Fig 2, Fig 5, Fig
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6). Such synergism was evident when progesterone levels were 
probably closer to the expected physiological progesterone 
level seen during proestrus. When progesterone was 
administered acutely (s.c.) to estradiol-primed rats, the 
resulting stimulation of LH release in response to centrally 
administered oxytocin demonstrated a bell-shaped dose response 
(Fig 5, Fig 6). The results indicate that the lower doses of 
progesterone synergistically enhance the ability of oxytocin 
to stimulate LH release in animals having physiologically high 
levels of serum estradiol. The enhancement was maximum after 
administration of 2.5 mg progesterone, but was also seen to a 
lesser degree in animals treated with 1.5 and 0.5 mg 
progesterone. As the dose of progesterone increased further, 
the synergism decreased. At the optimum progesterone dose , 
the level of LH stimulation was similar to that observed in 
intact proestrous rats during the spontaneous LH surge, and is 
higher than that observed in intact rats early on proestrus 30 
min after oxytocin injection. These differences are most 
likely due to differences in the progesterone levels and 
duration in the current experiments compared to intact cycling 
rats. In particular, lower doses of progesterone may be 
important to stimulate the start of the oxytocin-induced LH 
release in estradiol-primed ovariectomized rats, whereas 
larger doses may help bring the LH surge back down to normal. 
Interestingly, the lowest dose of progesterone in our study 
(0.5 mg) stimulated oxytocin-induced LH release in a modest
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biphasic manner (Fig 6). These data suggest low doses of 
progesterone might start the oxytocin-induced LH release in 
estradiol-primed ovariectomized rats, and that this 
stimulation of LH secretion could be brought back to normal as 
progesterone levels continue to rise.
The cellular mechanisms involved in the acute 
progesterone enhancement of oxytocin's stimulatory effect on 
LH release in estradiol primed, ovariectomized rats is 
unclear. No effect of progesterone on LHRH receptor number in 
the pituitary has been reported, suggesting the site of 
progesterone action must be at a level higher than the LHRH 
receptor (110). Other reports show that progesterone enhances 
the pituitary LH response to other secretagogues which act 
prior to the LHRH receptor (111) . The results from our present 
study suggest that the action of progesterone may be required 
for a functional interaction between oxytocin, other 
neuropeptides and their receptors. Alternatively, progesterone 
may activate additional mechanisms which estradiol does not 
affect, which are then required for the facilitation of LH 
secretion by oxytocin.
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CHAPTER VI 
SUMMARY
In summary, both estradiol and progesterone exert 
negative feedback effects on basal LH secretion, and their 
combined effect was additive. Centrally administered oxytocin 
inhibited the high plasma LH levels seen in ovariectomized 
rats. In contrast, in most cases, oxytocin caused LH levels to 
increase in estradiol-treated rats following its icv 
injection, although the magnitude of that increase is very 
small compared to the proestrous surge or the estradiol-primed 
rat given 2.5 mg progesterone. In animals treated with 
progesterone, alone, there was little effect of centrally 
administered oxytocin on plasma LH. Oxytocin did not alter 
plasma LH concentrations in animals treated with long term 
progesterone and/or estradiol. The results support the fact 
that the stimulatory effect of centrally administered oxytocin 
can be seen in a pharmacological model of the proestrous 
female rat, and that the presence of physiologically high 
levels of estradiol are critical for the stimulatory effect of 
oxytocin to be seen. In the absence of estradiol or 
progesterone, oxytocin exerts an inhibitory influence on 
plasma LH. The level of stimulation by oxytocin on plasma LH 
was critically dependent on the optimal dose of progesterone. 
Progesterone's influence on the oxytocin-induced change in LH 
release was both dose and time dependent. Low doses of
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progesterone synergistically enhance» while high doses 
inhibit» the ability of oxytocin administered centrally to 
stimulate LH secretion. The fact that the optimal dose of 
progesterone can influence oxytocin-induced LH release in a 
manner similar to that seen in cycling female rats on the 
afternoon of proestrus» and even stimulate LH release at 30 
min after icv oxytocin suggests that the duration and/or dose 
of estradiol and progesterone exposure are critical for the 
expression of the stimulatory oxytocin effect. On the other 
hand» the progesterone levels seen in intact female rats on 
proestrus are dynamic » and are probably lower than that seen 
in most of the acutely progesterone-treated » ovariectomized 
groups. The dynamic changes occuring in plasma estradiol and 
progesterone in relation to each other throughout proestrus 
are probably critically important to the expression of the 
oxytocin stimulation of LH secretion. Alternatively, it is 
possible that if other critically important key 
elements/inputs were also stimulated in the present 
experiments» or if the oxytocin challenge could be given at 
the time of the endogenous surge » the resulting surge of LH 
might resemble even more closely that seen on the afternoon of 
proestrus prior to ovulation in intact» cycling rats. When 
ovariectomized rats are estradiol-primed» and the 
progesterone level is carefully controlled» oxytocin given 
centrally induces an increase in plasma LH which resembles 
the endogenous LH surge seen on the afternoon of proestrus
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in the cycling, intact female rat. The pharmacological model 
of the proestrous surge can be used to evaluate the 
influence of oxytocin on LH secretion, as well as the 
important interaction, occurring between oxytocin and other 
central neurotransmitters to provide that regulation.
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